Tumorouos xanthomas in a young male with familial hypercholdesterolaemia

Rajput, R.; Bhansali, A.
October 2006
Archives of Disease in Childhood;Oct2006, Vol. 91 Issue 10, p827
Academic Journal
The article reports on the medical case of a 16-year-old boy who presented with massive bilateral tumorous swellings over his buttocks and who was diagnosed later with tumorous xanthomas with familial hypercholesterolemia. Xanthomas are manifestations of disordered lipid metabolism. Tuberous xanthomas are associated with raised low density lipoprotein levels. The patient was given 80-milligram atorvastatin and 10-milligram ezetimibe.


Related Articles

  • Homozygous Familial Hypercholesterolemia. Choh, Suhil A.; Choh, Naseer A.; Rasool, Akhter; Yousuf, Roomi; Qureshi, Umar // Journal of Pediatric Endocrinology & Metabolism;Jun2009, Vol. 22 Issue 6, p573 

    The article presents the case of a 7 year-old boy suffering from homozygous familial hypercholesterolemia (HFH). FH is a dominant disorder of lipid metabolism characterized by an elevated level of low density cholesterol, tendon xanthomas, and premature cardiovascular disease. HFH occurs very...

  • Monounsaturated fat increased the effectiveness of cholesterol-lowering diets.  // Australian Journal of Pharmacy;Sep2011, Vol. 92 Issue 1096, p100 

    The article presents a study that determined whether increasing the monounsaturated fat content of a diet proven effective for lowering low-density lipoprotein (LDL) cholesterol. The study was conducted on twenty-four patients with hyperlipidaemia and were given a therapeutic diet very low in...

  • Atherogenic Dyslipidemia -- A Medical Underwriter's Iceberg. Gleeson, Robert // Journal of Insurance Medicine;2009, Vol. 41 Issue 4, p264 

    Life insurance medical underwriters assess cardiovascular risk by applying versions of cholesterol guidelines that were written in the early 1980s, when people were not obese, triglyceride levels were lower, and the low-density lipoprotein particles carried 95% of the cholesterol ester. Today in...

  • Using Apolipoprotein B to Manage Dyslipidemic Patients: rilime for a Change? Harper, Charles R.; Jacobson, Terry A. // Mayo Clinic Proceedings;May2010, Vol. 85 Issue 5, p440 

    In this article the authors discuss the management of dyslipidemic patients using Apolipoprotein B (Apo B). The authors stress the establishment of low-density lipoprotein cholesterol (LDL-C) concentration as the independent risk factor for the development of atherosclerosis. The authors mention...

  • xanthomatosis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2507 

    A definition of the term "xanthomatosis," which refers to a condition in which lipid deposits are found in the tissues and can be accompanied by hyperlipemia, is presented.

  • Increased Frequency of Apo E-ND Phenotype and Hyperapobeta-lipoproteinemia in Normolipidemic Subjects with Xanthelasmas of the Eyelids. Douste-Blazy, Phillipe; Marcel, Yves L.; Cohen, Linda; Giroux, Jean-Mario; Davignon, Jean // Annals of Internal Medicine;Feb82, Vol. 96 Issue 2, p164 

    Presents a study which measured apolipoprotein E isomorphs in very low density lipoproteins and apolipoprotein B of low density lipoproteins in the plasma of normolipidemic subjects with xanthelasmas of the eyelids. Methodology; Results; Discussion.

  • Management of a Patient With a Null Low-Density Lipoprotein Receptor Mutation: A Case Report. Kolovou, Genovefa D.; Dedoussis, George V. Z.; Anagnostopoulou, Katherine K.; Hatzigeorgiou, George Ch.; Salpea, Klelia D.; Choumerianou, Despoina M.; Rammos, Spyridon; Mikhailidis, Dimitri P.; Cokkinos, Dennis V. // Angiology;Dec2006/Jan2007, Vol. 57 Issue 6, p729 

    A 13-year-old Greek boy with severe dyslipidemia, large tuberous xanthomas over the knees and elbows, Achilles' tendon xanthomas, and a bilateral corneal arcus was referred to the Lipid Clinic. He had a supravalvular aortic stenosis, 50% to 60% stenosis of both carotid arteries, and normal...

  • Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Aguilar-Salinas, Carlos A.; G�mez-P�rez, Francisco J.; Rull, Juan; Villalpando, Salvador; Barquera, Sim�n; Rojas, Rosalba // Salud P�blica de M�xico;may2010 supplement 1, Vol. 52, pS44 

    Objective. To describe the prevalence of lipid abnormalities found in the Mexican National Health and Nutrition Survey 2006 (ENSANUT2006). Material and Methods. Information was obtained from 4 040 subjects aged 20 to 69 years, studied after a 9- to 12-hour fast. Results. Median lipid...

  • Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system. G�mez-P�rez, Francisco J.; Rojas, Rosalba; Villalpando, Salvador; Barquera, Sim�n; Rull, Juan; Aguilar-Salinas, Carlos A. // Salud P�blica de M�xico;may2010 supplement 1, Vol. 52, pS54 

    Objective. To estimate the percentage of Mexican adults that may require lipid-lowering treatment according to National Cholesterol Education Program-III guidelines, using data from the National Health and Nutrition Survey 2006 (ENSANUT2006). Material and Methods. Information was obtained from 4...


Read the Article


Sign out of this library

Other Topics